Status:

COMPLETED

Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury

Lead Sponsor:

University of Cambridge

Collaborating Sponsors:

Cambridge University Hospitals NHS Foundation Trust

British Heart Foundation

Conditions:

COVID19

Cardiovascular Diseases

Eligibility:

All Genders

18-99 years

Brief Summary

Cardiovascular involvement in coronavirus disease-2019 (COVID-19) encompasses a wide range of vascular and myocardial pathologies, including both acute and long-term sequelae. The MIIC-MI study aims t...

Detailed Description

Cardiovascular involvement in coronavirus disease-2019 (COVID-19) encompasses a wide range of vascular and myocardial pathologies, including both acute and long-term sequelae. Cardiac Troponin elevat...

Eligibility Criteria

Inclusion

  • Patients \>18 years old
  • Confirmed COVID-19 infection AND Troponin I elevation \>99th percentile of upper reference limit OR new-onset heart failure OR unexplained cardiac symptoms
  • Able to give written, informed consent

Exclusion

  • Women of child-bearing potential not using adequate contraception
  • Contra-indication to MRI scanning
  • Contrast allergy or contrast-nephropathy
  • Chronic kidney disease (eGFR \<30 mL/min/1.73 m2)
  • Previous myocardial infarction
  • Uncontrolled atrial fibrillation
  • Uncontrolled chronic inflammatory disease
  • Severe lymphopenia (\<0.2 x109/L)
  • Treatment with immunomodulatory therapies within the last month (excluding inhaled or topical steroid therapy)
  • Any medical condition, in the opinion of the investigator, that prevents the participant from lying flat during scanning, or from participating in the study

Key Trial Info

Start Date :

July 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2023

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT04412369

Start Date

July 1 2020

End Date

August 1 2023

Last Update

July 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cambridge Univeristy Hospitals NHS Foundation Trust

Cambridge, United Kingdom, CB2 0QQ

Multi-modality Imaging & Immunophenotyping of COVID-19 Related Myocardial Injury | DecenTrialz